FDA Drug Recalls

Recalls / Class III

Class IIID-1367-2020

Product

Timolol Maleate USP, 0.5%, 5 mL, Sterile Opthalmic Solution, Rx Only, For Topical Application in the Eye, Distributed by: Rising Pharmaceuticals, Inc. Saddle Brook, NJ 07663, Manufactured by: FDC Limited B-8, MIDC Industrial Area, Waluj, Aurangbad - 431 136 Marahastra, India, NDC 64980-514-05

Brand name
Timolol Maleate
Generic name
Timolol Maleate
Active ingredient
Timolol Maleate
Route
Ophthalmic
NDCs
64980-513, 64980-514
FDA application
ANDA077259
Affected lot / code info
Lot # 089A016, Exp 12/31/2020

Why it was recalled

Labeling: Label mix-up: A case of Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml, had the outer carton for Timolol Maleate Sterile Ophthalmic solution USP 0.5%, 5ml but the bottle inside was Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml.

Recalling firm

Firm
Rising Pharmaceuticals, Inc.
Manufacturer
Rising Pharma Holdings, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
250 Pehle Ave Ste 601, N/A, Saddle Brook, New Jersey 07663-5832

Distribution

Quantity
N/A
Distribution pattern
U.S.A. Nationwide

Timeline

Recall initiated
2019-11-15
FDA classified
2020-06-29
Posted by FDA
2020-07-01
Terminated
2022-08-22
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1367-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.